Products - Metabolic conditions | Topic | NICE

Showing 4 products

Date | Title

Guidance programme: Highly specialised technologies guidanceRemove ‘Guidance programme: Highly specialised technologies guidance’ filter

Leriglitazone for treating cerebral adrenoleukodystrophy in boys and men 2 years and over [ID3903]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Sodium zirconium cyclosilicate for treating hyperkalaemia (partial review of TA599) [ID6439]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Doxecitine–doxribtimine for treating thymidine kinase 2 deficiency in people of any age [ID6484]
Status:
In development
Programme:
Highly specialised technologies guidance
Expected publication date:
TBC
Govorestat for treating classic galactosemia in people 2 to 65 years [TSID12071]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC